Jazz Pharmaceuticals

VYXEOS

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / VYXEOS – J9153

Manufacturer:

Jazz Pharmaceuticals

Name:

VYXEOS

HCPCS Code Descriptor:

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

Category:

J Code

HCPCS:

J9153

NDC(s):

68727-0745-01, 68727-0745-02

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

VYXEOS is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9153 is aligned to the drug VYXEOS.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/19

HCPCS Short Description:

Inj daunorubicin, cytarabine

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.jazzcares.com/

VYXEOS - J9153